• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产前暴露于甲巯咪唑的不良反应。

Adverse effects of prenatal methimazole exposure.

作者信息

Di Gianantonio E, Schaefer C, Mastroiacovo P P, Cournot M P, Benedicenti F, Reuvers M, Occupati B, Robert E, Bellemin B, Addis A, Arnon J, Clementi M

机构信息

Servizio di Informazione Teratologica (SIT), Genetica Clinica ed Epidemiologica, University of Padua, 35128 Padua, Italy.

出版信息

Teratology. 2001 Nov;64(5):262-6. doi: 10.1002/tera.1072.

DOI:10.1002/tera.1072
PMID:11745832
Abstract

BACKGROUND

A specific phenotype of methimazole (MMI) induced malformations has recently been postulated. MMI embryopathy is characterized by minor dysmorphic features, choanal atresia and/or esophageal atresia, growth retardation, and developmental delay.

METHODS

We prospectively studied the outcome of pregnancy in 241 women counseled by 10 Teratology Information Services (TIS) of the European Network of Teratology Information Services (ENTIS) because of MMI exposure, and compared them with those of 1,089 pregnant women referred to TIS because of exposure to nonteratogenic drugs (control group). Information was obtained by mail or telephone interview.

RESULTS

There was no increase in the general rate of major anomalies or of spontaneous or induced abortions in the MMI-exposed group in comparison with the control group. Two newborns were affected with one of the major malformations that are part of the postulated embryopathy.

CONCLUSIONS

The results of this study indicate that choanal as well as esophageal atresia may have a higher incidence than expected in fetuses exposed to MMI between 3 and 7 gestational weeks. Until further data are available, thyrotoxicosis should be treated with propylthiouracil, as it is apparently safer for use during the fertile period.

摘要

背景

最近有人提出甲巯咪唑(MMI)诱导畸形存在一种特定的表型。MMI胚胎病的特征为轻微的畸形特征、后鼻孔闭锁和/或食管闭锁、生长发育迟缓以及发育延迟。

方法

我们前瞻性地研究了欧洲致畸学信息服务网络(ENTIS)的10个致畸学信息服务机构(TIS)为241名因接触MMI前来咨询的女性的妊娠结局,并将其与1089名因接触非致畸性药物前来TIS咨询的孕妇(对照组)的妊娠结局进行比较。通过邮件或电话访谈获取信息。

结果

与对照组相比,MMI暴露组的主要畸形、自然流产或人工流产的总体发生率没有增加。有两名新生儿出现了被认为是胚胎病一部分的主要畸形之一。

结论

本研究结果表明,在妊娠第3至7周接触MMI的胎儿中,后鼻孔闭锁和食管闭锁的发生率可能高于预期。在有更多数据之前,甲状腺毒症应使用丙硫氧嘧啶治疗,因为它在育龄期使用显然更安全。

相似文献

1
Adverse effects of prenatal methimazole exposure.产前暴露于甲巯咪唑的不良反应。
Teratology. 2001 Nov;64(5):262-6. doi: 10.1002/tera.1072.
2
[Possible teratogenic effects of thiamazole].[甲巯咪唑可能的致畸作用]
Ned Tijdschr Geneeskd. 2006 Jan 14;150(2):101-4.
3
Methimazole embryopathy: delineation of the phenotype.甲巯咪唑胚胎病:表型的描述
Am J Med Genet. 1999 Mar 5;83(1):43-6.
4
Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.孕期用药上市后监测系统——ENTIS的15年经验
Reprod Toxicol. 2005 Sep-Oct;20(3):331-43. doi: 10.1016/j.reprotox.2005.03.012.
5
Pregnancy outcome after exposure to ranitidine and other H2-blockers. A collaborative study of the European Network of Teratology Information Services.雷尼替丁及其他H2受体阻滞剂暴露后的妊娠结局。欧洲致畸学信息服务网络的一项合作研究。
Reprod Toxicol. 2005 Mar-Apr;19(4):453-8. doi: 10.1016/j.reprotox.2004.09.002.
6
Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.抗甲状腺药物治疗 Graves 病与妊娠早期先天畸形的患病率。
J Clin Endocrinol Metab. 2012 Jul;97(7):2396-403. doi: 10.1210/jc.2011-2860. Epub 2012 Apr 30.
7
The safety of cetirizine during pregnancy. A prospective observational cohort study.西替利嗪在孕期的安全性。一项前瞻性观察性队列研究。
Reprod Toxicol. 2008 Sep;26(1):19-23. doi: 10.1016/j.reprotox.2008.05.053. Epub 2008 May 13.
8
The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.孕期钙通道阻滞剂的安全性:一项前瞻性、多中心观察性研究。
Reprod Toxicol. 2008 Sep;26(1):24-30. doi: 10.1016/j.reprotox.2008.05.065. Epub 2008 Jun 7.
9
Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.妊娠期暴露于甲硝唑后的妊娠结局:一项前瞻性对照队列研究。
Teratology. 2001 May;63(5):186-92. doi: 10.1002/tera.1033.
10
Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.孕早期暴露于佐匹克隆后的妊娠结局:一项前瞻性对照队列研究。
Am J Perinatol. 1999;16(4):157-60. doi: 10.1055/s-2007-993850.

引用本文的文献

1
Compensatory mechanisms in response to induced hypothyroidism in the late gestation pig fetus†.孕晚期猪胎甲状腺功能减退诱导时的补偿机制。
Biol Reprod. 2023 May 10;108(5):731-743. doi: 10.1093/biolre/ioad024.
2
Evaluation of potential thiamazole exposure of owners of orally treated hyperthyroid cats.评估接受口服药物治疗的甲状腺机能亢进猫的主人潜在的甲巯咪唑暴露情况。
J Feline Med Surg. 2022 Jun;24(6):e138-e141. doi: 10.1177/1098612X221091738. Epub 2022 Apr 26.
3
Antithyroid drug use during pregnancy and the risk of birth defects in offspring: systematic review and meta-analysis of observational studies with methodological considerations.
抗甲状腺药物在孕期的使用与子代出生缺陷风险:考虑方法学因素的观察性研究的系统评价和荟萃分析。
Br J Clin Pharmacol. 2021 Oct;87(10):3890-3900. doi: 10.1111/bcp.14805. Epub 2021 Mar 30.
4
Histological, immunohistochemical and transcriptomic characterization of human tracheoesophageal fistulas.人气管食管瘘的组织学、免疫组织化学和转录组学特征。
PLoS One. 2020 Nov 17;15(11):e0242167. doi: 10.1371/journal.pone.0242167. eCollection 2020.
5
Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.硫脲类药物治疗格雷夫斯甲亢:妊娠适应证和安全性的立场文件。
J Endocrinol Invest. 2020 Feb;43(2):257-265. doi: 10.1007/s40618-019-01148-w. Epub 2019 Nov 29.
6
Thyroid-Stimulating Hormone Receptor Antibodies in Pregnancy: Clinical Relevance.孕期促甲状腺激素受体抗体:临床意义
Front Endocrinol (Lausanne). 2017 Jun 30;8:137. doi: 10.3389/fendo.2017.00137. eCollection 2017.
7
Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.孕期暴露于甲巯咪唑和丙硫氧嘧啶对新生儿先天性畸形风险的影响:一项荟萃分析。
PLoS One. 2017 Jul 3;12(7):e0180108. doi: 10.1371/journal.pone.0180108. eCollection 2017.
8
Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.孕期抗甲状腺治疗与先天性异常的风险:一项荟萃分析。
Clinics (Sao Paulo). 2015 Jun;70(6):453-9. doi: 10.6061/clinics/2015(06)12. Epub 2015 Jun 1.
9
Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.子宫内接触抗甲状腺药物的儿童先天性异常:队列研究的荟萃分析。
PLoS One. 2015 May 14;10(5):e0126610. doi: 10.1371/journal.pone.0126610. eCollection 2015.
10
Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.孕期接受甲巯咪唑或丙硫氧嘧啶治疗的女性的妊娠结局。
J Endocrinol Invest. 2015 Sep;38(9):977-85. doi: 10.1007/s40618-015-0281-z. Epub 2015 Apr 4.